CLINICAL_TRIALS
trial_result
· 2016-02-09
Clinical Trial Update: An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome [Phase 3]
Summary
Phase 3 trial evaluating efficacy and safety of Somatuline Depot (lanreotide) for carcinoid syndrome has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Carcinoid Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2016-02-09